PrimaryCareNOW | Thursday, January 14


Thank you to all who joined us live for PrimaryCareNOW on Thursday, January 14. If you were not able to join us, most sessions have been recorded and are available below.

Upcoming Virtual Conferences
Pri-Med has more virtual education planned. View our upcoming virtual conference schedule.

Upcoming Conferences


  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Infectious Disease

Managing Influenza: Practical Strategies For Primary Care

Daniel A. Solomon, MD | Charles Vega, MD, FAAFP


This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Daniel A. Solomon, MD

Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine, Harvard Medical School, Boston, MA

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by an educational grant from Genentech, a member of the Roche Group

9:10–10:10am ET    CME/CE Accredited Session


Proactive Management of Iron Deficiency Anemia: An Update for the Primary Care Provider

Neilanjan Nandi, MD, FACP


This session reviews the latest evidence-based data regarding iron deficiency anemia (IDA) and offers practical clinical insight into the diagnosis and management of this common condition. Through a series of case presentations, the presenting gastroenterologist discusses the common but subtle manifestations of IDA, proactive strategies for recognizing patients at risk of IDA, and the current evidence base for using oral and intravenous iron therapies effectively in practice. These practical pearls and pitfalls are intended to help optimize the care of IDA in various patient populations seen in the primary care setting. 

Neilanjan Nandi, MD, FACP

Associate Professor of Clinical Medicine, Inflammatory Bowel Diseases Center, University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, PA

Supported by American Regent, Inc.

10:20–11:05am ET    Non-CME Industry Theater


Developments in VTE Prophylaxis of Acutely Ill Medical Patients and Treatment of DVT/PE

James Neuenschwander, MD, FACEP


Discussion on developments in VTE Prophylaxis of Acutely Ill Medical Patients and treatment of DVT/PE.

James Neuenschwander, MD, FACEP

Genesis Healthcare Systems/Ohio State University Medical Center

Sponsored by Janssen Pharmaceuticals, Inc.

11:15am–12:15pm ET    CME/CE Accredited Session

Hot Topics

A Year in Review: Top Practice-Changing Evidence from 2020

Charles Vega, MD, FAAFP


Review practice-changing articles from 2020! During this informative session on medical literature updates (excluding COVID-19), primary care physician, Dr. Charles Vega, will review the clinical implications of practice-changing literature that has been recently published.  Topics for discussion will include: HPV vaccination, mammography, colorectal cancer screening, osteoporosis, coconut oil, milk and weight gain, mask efficacy, COPD exacerbations, medication-assisted treatment for opioid disorder and more! You don’t want to miss these important updates!

Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 01/14/2021, and they are subject to change as new information is published.

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

12:25–1:10pm ET    Non-CME Industry Theater


Uncontrolled Asthma: Changing the Patient Experience

Matthew Mintz, MD, FACP


This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Matthew Mintz, MD, FACP

Associate Clinical Professor of Medicine at George Washington University School of Medicine & Health Sciences, Internal Medicine and Primary Care Physician, Private Practice in Bethesda, Maryland

Sponsored by GlaxoSmithKline

12:25–1:10pm ET    Non-CME Industry Theater


The Interconnected Cardio-Renal-Metabolic (CRM) Systems

Rachel Pessah-Pollack, MD, FACE | Pam R. Taub, MD, FACC


The objectives of the program are to: 

  • Review the interconnected nature of the CRM systems 
  • Identify the shared risk factors that contribute to the development and progression of clinically comorbid conditions within these systems
  • Discuss the impact of coexisting conditions of the CRM systems and the continuum of risk
  • Highlight a collaborative care approach for patients who are at risk for or have established disorders of the CRM systems

Rachel Pessah-Pollack, MD, FACE

Clinical Associate Professor, NYU Grossman School of Medicine, New York, NY

Pam R. Taub, MD, FACC

Associate Professor of Medicine, UC San Diego Health System, San Diego, California

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

1:20–4:50pm ET    CME/CE Accredited Session


Strategies for Effective Pain Management

Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP


The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain versus the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse to manage patients’ pain and medication use optimally.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). 

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

5–5:45pm ET    Non-CME Industry Theater


Clinical Considerations in Stroke or Transient Ischemic Attack

Ted Okerson, MD, FACP, FACE


  • Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
  • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population
  • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial

Ted Okerson, MD, FACP, FACE

Sponsored by AstraZeneca Pharmaceuticals, LP